The optimal 18F-fluoromisonidazole PET threshold to define tumor hypoxia in preclinical squamous cell carcinomas using pO2 electron paramagnetic resonance imaging as reference truth

Inna Gertsenshteyn, Boris Epel, Amandeep Ahluwalia, Heejong Kim, Xiaobing Fan, Eugene Barth, Marta Zamora, Erica Markiewicz, Hsiu-Ming Tsai, Subramanian Sundramoorthy, Lara Leoni, John Lukens, Mohammed Bhuiyan, Richard Freifelder, Anna Kucharski, Mihai Giurcanu, Brian B. Roman, Gregory Karczmar, Chien-Min Kao, Howard Halpern, Chin-Tu Chen

Open source

DOI: 10.1007/s00259-022-05889-4
Published: 2022-07-06
Container: European Journal of Nuclear Medicine and Molecular Imaging
Publisher: Springer Science and Business Media LLC
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1007/s00259-022-05889-4,
  title = {The optimal 18F-fluoromisonidazole PET threshold to define tumor hypoxia in preclinical squamous cell carcinomas using pO2 electron paramagnetic resonance imaging as reference truth},
  author = {Inna Gertsenshteyn and Boris Epel and Amandeep Ahluwalia and Heejong Kim and Xiaobing Fan and Eugene Barth and Marta Zamora and Erica Markiewicz and Hsiu-Ming Tsai and Subramanian Sundramoorthy and Lara Leoni and John Lukens and Mohammed Bhuiyan and Richard Freifelder and Anna Kucharski and Mihai Giurcanu and Brian B. Roman and Gregory Karczmar and Chien-Min Kao and Howard Halpern and Chin-Tu Chen},
  year = {2022},
  journal = {European Journal of Nuclear Medicine and Molecular Imaging},
  doi = {10.1007/s00259-022-05889-4},
  url = {https://doi.org/10.1007/s00259-022-05889-4}
}

RIS

TY  - JOUR
TI  - The optimal 18F-fluoromisonidazole PET threshold to define tumor hypoxia in preclinical squamous cell carcinomas using pO2 electron paramagnetic resonance imaging as reference truth
AU  - Inna Gertsenshteyn
AU  - Boris Epel
AU  - Amandeep Ahluwalia
AU  - Heejong Kim
AU  - Xiaobing Fan
AU  - Eugene Barth
AU  - Marta Zamora
AU  - Erica Markiewicz
AU  - Hsiu-Ming Tsai
AU  - Subramanian Sundramoorthy
AU  - Lara Leoni
AU  - John Lukens
AU  - Mohammed Bhuiyan
AU  - Richard Freifelder
AU  - Anna Kucharski
AU  - Mihai Giurcanu
AU  - Brian B. Roman
AU  - Gregory Karczmar
AU  - Chien-Min Kao
AU  - Howard Halpern
AU  - Chin-Tu Chen
PY  - 2022
JO  - European Journal of Nuclear Medicine and Molecular Imaging
DO  - 10.1007/s00259-022-05889-4
UR  - https://doi.org/10.1007/s00259-022-05889-4
ER  -

APA

Gertsenshteyn, I., Epel, B., Ahluwalia, A., Kim, H., Fan, X., Barth, E., Zamora, M., Markiewicz, E., Tsai, H., Sundramoorthy, S., Leoni, L., Lukens, J., Bhuiyan, M., Freifelder, R., Kucharski, A., Giurcanu, M., Roman, B. B., Karczmar, G., Kao, C., Halpern, H., & Chen, C. (2022). The optimal 18F-fluoromisonidazole PET threshold to define tumor hypoxia in preclinical squamous cell carcinomas using pO2 electron paramagnetic resonance imaging as reference truth. European Journal of Nuclear Medicine and Molecular Imaging. https://doi.org/10.1007/s00259-022-05889-4

Source records

crossref · retrieved 2026-09-26T16:42:35.438Z